113 related articles for article (PubMed ID: 56216)
1. Effect of surgical and chemotherapeutic treatment on alpha-fetoprotein levels in patients with hepatocellular carcinoma.
McIntire KR; Vogel CL; Primack A; Waldmann TA; Kyalwazi SK
Cancer; 1976 Feb; 37(2):677-83. PubMed ID: 56216
[TBL] [Abstract][Full Text] [Related]
2. Clinical significance of simultaneous determinations of alpha-fetoprotein and des-gamma-carboxy prothrombin in monitoring recurrence in patients with hepatocellular carcinoma.
Aoyagi Y; Oguro M; Yanagi M; Mita Y; Suda T; Suzuki Y; Hata K; Ichii K; Asakura H
Cancer; 1996 May; 77(9):1781-6. PubMed ID: 8646674
[TBL] [Abstract][Full Text] [Related]
3. Serum alpha-fetoprotein levels after hepatic artery ligation and postoperative chemotherapy: correlation with clinical status in patients with hepatocellular carcinoma.
Nagasue N; Inokuchi K; Kobayashi M; Saku M
Cancer; 1977 Aug; 40(2):615-8. PubMed ID: 70265
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of hepatoma chemotherapy by alpha-fetoprotein determination.
Matsumoto Y; Suzuki T; Ono H; Nakase A; Honjo I
Am J Surg; 1976 Sep; 132(3):325-8. PubMed ID: 60886
[TBL] [Abstract][Full Text] [Related]
5. Serum alpha-fetoprotein level per tumor volume reflects prognosis in patients with hepatocellular carcinoma after curative hepatectomy.
Furihata T; Sawada T; Kita J; Iso Y; Kato M; Rokkaku K; Shimoda M; Kubota K
Hepatogastroenterology; 2008; 55(86-87):1705-9. PubMed ID: 19102374
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of curability and prediction of prognosis after surgical treatment for hepatocellular carcinoma by lens culinaris agglutinin-reactive alpha-fetoprotein.
Okuda K; Tanaka M; Kanazawa N; Nagashima J; Satomura S; Kinoshita H; Eriguchi N; Aoyagi S; Kojiro M
Int J Oncol; 1999 Feb; 14(2):265-71. PubMed ID: 9917501
[TBL] [Abstract][Full Text] [Related]
7. Clinical observations during a relatively early stage of hepatocellular carcinoma, with special reference to serum alpha-fetoprotein levels.
Okuda K; Kotoda K; Obata H; Hayashi N; Hisamitsu T
Gastroenterology; 1975 Jul; 69(1):226-34. PubMed ID: 50251
[TBL] [Abstract][Full Text] [Related]
8. Serum alpha-fetoprotein estimations and doubling time in hepatocellular carcinoma: influence of therapy and possible value in early detection.
Johnson PJ; Williams R
J Natl Cancer Inst; 1980 Jun; 64(6):1329-32. PubMed ID: 6154822
[TBL] [Abstract][Full Text] [Related]
9. Editorial: Alpha 1-fetoprotein: need for quantitative assays.
Alpert E
N Engl J Med; 1974 Mar; 290(10):568-9. PubMed ID: 4129924
[TBL] [Abstract][Full Text] [Related]
10. Elevation of alpha-fetoprotein level without evidence of recurrence after hepatectomy for hepatocellular carcinoma.
Ezaki T; Yukaya H; Ogawa Y; Chang YC; Nagasue N
Cancer; 1988 May; 61(9):1880-3. PubMed ID: 2451558
[TBL] [Abstract][Full Text] [Related]
11. Postoperative serum alpha-fetoprotein level is a useful predictor of recurrence after hepatectomy for hepatocellular carcinoma.
Nobuoka D; Kato Y; Gotohda N; Takahashi S; Nakagohri T; Konishi M; Kinoshita T; Nakatsura T
Oncol Rep; 2010 Aug; 24(2):521-8. PubMed ID: 20596642
[TBL] [Abstract][Full Text] [Related]
12. [Correlation between serum alpha-fetoprotein variant levels in patients with hepatocellular carcinoma and the presence of alpha-fetoprotein mRNA in the circulating blood].
Kang XY; Yin ZF; Qian HH; Wu ZD; Yu ZX; Wu MC
Zhonghua Gan Zang Bing Za Zhi; 2003 Jan; 11(1):17-9. PubMed ID: 12546734
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic value of lectin reactive alpha-fetoprotein for neoinfantile hepatic tumors and malignant germ cell tumors: preliminary study.
Kinoshita Y; Tajiri T; Souzaki R; Tatsuta K; Higashi M; Izaki T; Takahashi Y; Taguchi T
J Pediatr Hematol Oncol; 2008 Jun; 30(6):447-50. PubMed ID: 18525461
[TBL] [Abstract][Full Text] [Related]
14. Clinical Significance of Preoperative Hepatocellular Carcinoma With High
Yamao T; Yamashita YI; Imai K; Umezaki N; Tsukamoto M; Kitano Y; Arima K; Miyata T; Nakagawa S; Okabe H; Hayashi H; Chikamoto A; Ishiko T; Baba H
Anticancer Res; 2019 Feb; 39(2):883-889. PubMed ID: 30711971
[TBL] [Abstract][Full Text] [Related]
15. [Significance of serum alpha-fetoprotein determination. Experiences with our own radioimmunoassay].
Lamerz R; Schmalhorst U; Grunst J; Fateh-Moghadam A; Eisenburg J
Fortschr Med; 1976 Apr; 94(12):702-10. PubMed ID: 61154
[TBL] [Abstract][Full Text] [Related]
16. Serial serum AFP heterogeneity changes in patients with hepatocellular carcinoma during chemotherapy.
Buamah PK; Cornell C; James OF; Skillen AW; Harris AL
Cancer Chemother Pharmacol; 1986; 17(2):182-4. PubMed ID: 2424626
[TBL] [Abstract][Full Text] [Related]
17. Half-life of serum alpha-fetoprotein: an early prognostic index of recurrence and survival after hepatic resection for hepatocellular carcinoma.
Shim JH; Han S; Lee YJ; Lee SG; Kim KM; Lim YS; Chung YH; Lee YS; Lee HC
Ann Surg; 2013 Apr; 257(4):708-17. PubMed ID: 23108121
[TBL] [Abstract][Full Text] [Related]
18. [Radioimmunologic determination of alpha fetoprotein in diagnosis of primary tumors of the liver].
Banfi F
Quad Sclavo Diagn; 1975 Jun; 11(2):415-8. PubMed ID: 57625
[TBL] [Abstract][Full Text] [Related]
19. Prognostic roles of preoperative α-fetoprotein and des-γ-carboxy prothrombin in hepatocellular carcinoma patients.
Meguro M; Mizuguchi T; Nishidate T; Okita K; Ishii M; Ota S; Ueki T; Akizuki E; Hirata K
World J Gastroenterol; 2015 Apr; 21(16):4933-45. PubMed ID: 25945007
[TBL] [Abstract][Full Text] [Related]
20. Serum alpha-fetoprotein response as a surrogate for clinical outcome in patients receiving systemic therapy for advanced hepatocellular carcinoma.
Vora SR; Zheng H; Stadler ZK; Fuchs CS; Zhu AX
Oncologist; 2009 Jul; 14(7):717-25. PubMed ID: 19581525
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
